What is the issue?
India has aligned its policy with the guideline of World Health Organisation which recommended that antiretroviral therapy (ART) be initiated in people living with HIV irrespective of the CD4 (a type of white-blood cell) counts.
What are the changes made to the guidelines?
Why WHO recommended this?
What are the challenges?
What is the way ahead?
Source: The Hindu